JAK inhibitors: Evolving therapies in rheumatoid arthritis

Journal Title: IP International Journal of Orthopaedic Rheumatology - Year 2018, Vol 4, Issue 2

Abstract

In rheumatoid arthritis there has been a paradigm shift from controlling symptoms to controlling the disease progress with abrogation of inflammation Achieving this remission or very low disease activity has become increasingly possible with USA FDA approved first JAK inhibitor Tofacitinib in November 2012 not in Europe This new small molecule JAK inhibitors are oral drug working intracellularly in comparison to TNF inhibitors targeting a singly cytokine within extracellular space confining themselves to cell surface receptors The second JAK inhibitor Baracitinib approved in Europe in February 2017 and in USA in May 2018 has greater promises Once daily 2 mg oral dose used either as monotherapy or in combination with methotrexate in moderate to severe active rheumatoid arthritis in adults have provided remission even in patients who have responded inadequately or are intolerant to one or more DMARDs bDMARDs It is a safe second line therapy after methotrexate In DMARD nave patients it is likely to become firstline agentsKeywords JAK inhibitor TNF inhibitor NSAID bDMARD Methotrexate Tofacitinib

Authors and Affiliations

Shiva Shankar Jha

Keywords

Related Articles

Comparative evaluation of the efficacy of locally delivered 0.1% curcumin irrigation, meswak irrigation and 0.2% CHX irrigation in management Chronic periodontitis patients

Introduction: Ayurvedic medicines like turmeric possess anti-inflammatory, anti-oxidant, and anti-microbial properties. This study was carried out using the purest form of turmeric and meswak to test their anti-plaque an...

En-mass excision and reconstruction of GCT in 1st metatarsal in incidentally diagnosed young diabetic: A case report

Giant Cell Tumour (GCT) which is a locally aggressive benign bone tumour with malignant potential rarely occurs in metatarsal. We present a case of GCT of first metatarsal bone in a 26 year old male with incidentally dia...

Journal of Indian Orthopaedic Rheumatology Association; July-December 2016:2(2); 81-85 81 A study of the relationship of anthropometric measurements with bone Mineral density in population in and around Bhopal

Objective: To collect the data of anthropometric measurement around District Bhopal, M.P and find out the relationship between BMI & BMD. Method: This was a cross sectional study in which anthropometric data of 489 perso...

Preponderance of side of involvement in Osteoarthritis knee

Introduction: Osteoarthritis (OA) is a chronic inflammatory condition affecting the joint. Knee is the most commonly involved joint of body in osteoarthritis. Osteoarthritis may occur primarily in knee joint or it may be...

A meta-analysis of outcomes in Colles fractures treated conservatively in elderly patients

Background: Fractures of the distal end of radius or Colles’ fracture was first described by Sir Abraham Colles in nineteenth century. It commonly occurs in the elderly people having osteoporosis. It is caused by fall on...

Download PDF file
  • EP ID EP486040
  • DOI 10.18231/2455-6777.2018.0011
  • Views 74
  • Downloads 0

How To Cite

Shiva Shankar Jha (2018). JAK inhibitors: Evolving therapies in rheumatoid arthritis. IP International Journal of Orthopaedic Rheumatology, 4(2), 43-46. https://europub.co.uk/articles/-A-486040